CareCloud Reports 16% Revenue Growth in Q2, Reaffirms Full-Year Outlook
CCLD sits 25% above its 52-week low of $2.04.
Summary
CareCloud posted Q2 revenue of $31.9M (+16% YoY) and GAAP net income of $1.1M, while reaffirming its full-year 2026 guidance for revenue, adjusted EBITDA, and EPS.
Key Events · Earnings and Guidance · CCLD
-
Revenue Grows 16% to $31.9M
Driven by technology-enabled solutions and the Empower acquisition, Q2 2026 revenue rose to $31.9M from $27.4M a year ago.
-
Ninth Straight Quarter of Profitability
GAAP net income came in at $1.1M, down from $2.9M in Q2 2025, as higher R&D spending on AI and increased interest expense from the Series B redemption weighed on the bottom line.
-
Full-Year Guidance Reaffirmed
Management reiterated its 2026 outlook: revenue of $128-132M, adjusted EBITDA of $29-31M, and GAAP EPS of $0.20-0.23.
-
Adjusted EBITDA of $5.9M
Adjusted EBITDA declined to $5.9M from $6.5M a year ago, reflecting deliberate investments in AI and integration costs that pressured near-term profitability.
Analysis · CCLD · Technology
Revenue climbed 16% to $31.9M, marking the ninth consecutive quarter of positive GAAP net income, and full-year guidance was reaffirmed — a steady quarter that preserves the AI-powered healthcare tech narrative. Profitability softened as the company channels funds into AI R&D and shoulders higher interest costs from the Series B redemption, but the reiterated outlook underscores management's confidence in the second half.
At the time of this filing, CCLD was trading at $2.54 on NASDAQ in the Technology sector, with a market capitalization of approximately $107.9M. The 52-week trading range was $2.04 to $4.01. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.